WALTHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that it has commenced underwritten public offerings of its convertible senior notes due 2032 (the “Convertible Notes” and such offering, the “Convertible Notes Offering ...

CRANFORD, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has completed its previously announced exchange offer to each holder of its Series C Non-Convertible Redeemable Preferred Stock, $0.01 par value per share (the “Series C Preferred Stock”), to exchange such Series C Preferred Stock for shares of Enzon’s common stock, $0.01 par value per share (the “Common Stock”). The offer and the withdrawal rights expired at 5:00 p ...

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Adamas Trust, Inc. (Nasdaq: ADAM) (the “Company” or “Adamas”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.23 per share on shares of its common stock for the quarter ending March 31, 2026. The dividend will be payable on April 28, 2026 to common stockholders of record as of the close of business on March 30, 2026. In addition, the Board declared cash dividends on the Company’s 8.000% Series D Fixed-to- ...

Core Viewpoint - Metropolitan Bank Holding Corp. has successfully closed an overallotment option, issuing an additional 213,395 shares of common stock at a price of $85.00 per share, resulting in expected proceeds of approximately $17.2 million after underwriting discounts [1]. Group 1: Offering Details - The underwriters for the public offering were UBS Investment Bank and Hovde Group, LLC, who acted as joint book-running managers [2]. - The offering was conducted under an effective shelf registration statement on Form S-3 filed with the SEC, including a preliminary and final prospectus supplement dated February 25, 2026 [3]. Group 2: Company Overview - Metropolitan Bank Holding Corp. (NYSE: MCB) is the parent company of Metropolitan Commercial Bank, a full-service commercial bank based in New York City, providing a wide range of banking products and services [5]. - The Bank has received recognition as one of Newsweek's Best Regional Banks in 2024 and 2025 and was ranked as a top ten loan producer among commercial banks with over $1 billion in assets in 2024 [6].

Core Viewpoint - Rosen Law Firm is reminding sellers of Masonite International Corporation common stock of a class action lawsuit with a lead plaintiff deadline of April 7, 2026, for those who sold shares between June 5, 2023, and February 8, 2024 [1]. Group 1: Class Action Details - Investors who sold Masonite common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3]. - The lawsuit alleges that defendants made material omissions and misrepresentations regarding Owens Corning's offers to purchase Masonite's stock at significant premiums, which could have indicated a higher value for Masonite's stock if disclosed [5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Investors have the option to remain absent class members and are not required to serve as lead plaintiffs to share in any potential recovery [7].

Core Viewpoint - Annaly Capital Management, Inc. has declared a cash dividend of $0.70 per common share for the first quarter of 2026, payable on April 30, 2026, to shareholders of record as of March 31, 2026 [1][1]. Company Overview - Annaly Capital Management, Inc. is a leading diversified capital manager with investment strategies focused on mortgage finance [1][1]. - The company's primary objective is to generate net income for distribution to stockholders while optimizing returns through prudent management of diversified investment strategies [1][1]. - Annaly is internally managed and has elected to be taxed as a real estate investment trust (REIT) for federal income tax purposes [1][1]. Dividend Details - The declared dividend of $0.70 per share is part of the company's ongoing commitment to return value to its shareholders [1][1]. - The ex-dividend date for this payment is also set for March 31, 2026 [1][1].

Core Viewpoint - Aureus Greenway Holdings Inc. has successfully closed a private placement, raising approximately $9.0 million through the issuance of common stock and pre-funded warrants [1][2][5]. Group 1: Private Placement Details - The company issued a total of 3,009,667 shares of common stock and/or pre-funded common stock purchase warrants at a price of $3.00 per share, resulting in gross proceeds of about $9.0 million before fees [2]. - The pre-funded warrants are immediately exercisable at a nominal price of $0.001 per share and will expire only when fully exercised [4]. - The transaction was conducted under exemptions from registration requirements as per Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b) of Regulation D [4]. Group 2: Use of Proceeds - The net proceeds from the private placement will be utilized for working capital and general corporate purposes, including expenses related to a proposed business combination with Autonomous Power Corporation [5]. Group 3: Company Overview - Aureus Greenway Holdings Inc. operates golf course properties in Florida, including Kissimmee Bay Country Club and Remington Golf Club in the greater Orlando region [8].

CRANFORD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expiration date for the exchange offer by the Company to each holder of its Series C Non-Convertible Redeemable Preferred Stock, $0.01 par value per share (the “Series C Preferred Stock”), to exchange such Series C Preferred Stock for shares of Enzon’s common stock, $0.01 par value per share (the “Common Stock”). After giving effect to the extension, ...

Core Viewpoint - Rithm Property Trust Inc. has authorized a stock repurchase program totaling $10 million, which will be executed through various means until March 1, 2027 [1] Summary by Relevant Categories Stock Repurchase Program - The Board of Directors of Rithm Property Trust Inc. has approved the repurchase of up to $10 million of the Company's Common Stock [1] - The repurchases may occur in the open market, through privately negotiated transactions, block trades, or other methods [1] - The program will comply with applicable securities laws and regulations [1]

Core Insights - Valley National Bancorp's board has authorized a new stock repurchase program for up to 25 million shares, effective from April 27, 2026, to April 27, 2028 [1][8] - The new program replaces the existing repurchase plan, which is set to expire on April 26, 2026 [2] Financial Performance - In 2025, Valley National repurchased 6.1 million shares at an average price of $10.41 per share, with approximately 18.9 million shares remaining under the previous authorization as of December 31, 2025 [2][4] - The company has maintained a quarterly dividend of 11 cents per share since 2018, resulting in an annualized dividend yield of 3.41% based on a closing price of $12.87, with a dividend payout ratio of 44% [3] Financial Position - As of December 31, 2025, Valley National had total debt of $3 billion, primarily long-term, and $1.58 billion in cash and interest-bearing deposits [4] - The company holds a BBB- investment-grade credit rating from S&P Global Ratings, indicating a strong position to meet near-term debt obligations and support capital distribution initiatives [4] Market Performance - Valley National's shares have increased by 13.4% over the past three months, outperforming the industry growth of 9% [5] - The company currently holds a Zacks Rank of 3 (Hold) [6]